Active Ingredient: CYTARABINE; DAUNORUBICIN
Proprietary Name: VYXEOS
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: 100MG;44MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N209401
Product Number: 001
Approval Date: Aug 3, 2017
Applicant Holder Full Name: CELATOR PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
